Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact on global healthcare and clinical practice. Cancer patients, in particular those with haematological m...

Descripción completa

Detalles Bibliográficos
Autores principales: Giesen, Nicola, Sprute, Rosanne, Rüthrich, Maria, Khodamoradi, Yascha, Mellinghoff, Sibylle C., Beutel, Gernot, Lueck, Catherina, Koldehoff, Michael, Hentrich, Marcus, Sandherr, Michael, von Bergwelt-Baildon, Michael, Wolf, Hans-Heinrich, Hirsch, Hans H., Wörmann, Bernhard, Cornely, Oliver A., Köhler, Philipp, Schalk, Enrico, von Lilienfeld-Toal, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505554/
https://www.ncbi.nlm.nih.gov/pubmed/33068941
http://dx.doi.org/10.1016/j.ejca.2020.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505554/
https://www.ncbi.nlm.nih.gov/pubmed/33068941
http://dx.doi.org/10.1016/j.ejca.2020.09.009

Ejemplares similares